PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment
Clinical trial NCT06157242 · COMPLETED
Trial details
- NCT number
- NCT06157242
- Sponsor
- Qpex Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-10
- Primary completion
- 2025-03-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.